Get 30% off on our Global Market Reports with code ONLINE30 – Hurry, limited time offer!

How Has The Rheumatic Heart Disease Market Size Shifted, And What Is the Outlook Through 2034?

The market size for rheumatic heart disease has seen substantial growth in the past few years. Projected growth indicates an increase from $2.56 billion in 2024 to $2.72 billion in 2025 with a compound annual growth rate (CAGR) of 6.3%. This growth during the historic period is due to several factors including the widespread incidence of untreated strep infections, poor access to healthcare services in low-income areas, limited knowledge about rheumatic heart disease, a delay in diagnosis and treatment, as well as ineffective vaccination initiatives.

Expectations for the rheumatic heart disease market suggest strong growth over the forthcoming years, with its size projected to reach $3.44 billion by 2029, reflecting a compound annual growth rate (CAGR) of 6.0%. Factors which may fuel this growth within the forecasted period include a rising interest in preventive screening programs, heightened awareness surrounding the importance of early detection, increased contributions towards healthcare in evolving regions, telemedicine development for remote diagnosis, and government-led prevention initiatives. Other burgeoning trends anticipated for the forecast period include the heightened use of AI in diagnostic procedures, expansion of screening via echocardiography, incorporation of mobile health solutions, advancements in anti-inflammatory treatments, and collaborations aimed at global eradication of the disease.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=23502&type=smp

Which Factors and External Forces Are Driving Demand in the Rheumatic Heart Disease Market?

The escalating incidence of strep throat is projected to spur the upswing of the rheumatic heart disease market in the future. Characterised as a bacterial infection caused by streptococcus pyogenes (Group A streptococcus), strep throat results in inflammation and painful discomfort in the throat, symptoms often paired with fever, swollen lymph nodes, and difficulties swallowing. The challenge of treating streptococcal infections is increasing due to heightened antibiotic resistance, which leads to lasting illness and increased transmission rates in societies. Rheumatic heart disease is a chronic complication resulting from untreated or recurring strep throat infections, underlining the critical need for prompt diagnosis and treatment of streptococcal infections to prevent serious heart damage. As an example, the US-based government department, Centers for Disease Control and Prevention, reported in April 2023 that strep throat results in an estimated 5.2 million outpatient visits per year among individuals below the age of 65. These incidences lead to 2.8 million antibiotic prescriptions on an annual basis. Thus, the escalating incidence of strep throat is accelerating the growth of the rheumatic heart disease market.

Which Segments in the Rheumatic Heart Disease Offer the Most Growth?

The rheumatic heart disease market covered in this report is segmented –

1) By Type: Valve, Myocarditis, Pericarditis

2) By Age Group: Pediatric, Adolescent, Adult, Geriatric

3) By Application: Hospital, Diagnostic Centre, Research Centre

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Direct Sales

Subsegments:

1) By Valve: Mitral Valve Disease, Aortic Valve Disease, Tricuspid Valve Disease, Pulmonary Valve Disease

2) By Myocarditis: Acute Myocarditis, Chronic Myocarditis, Fulminant Myocarditis

3) By Pericarditis: Acute Pericarditis, Chronic Pericarditis, Constrictive Pericarditis, Effusive Pericarditis

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=23502&type=smp

What Are the Fastest-Growing Geographies in the Rheumatic Heart Disease Market?

North America was the largest region in the rheumatic heart disease market in 2024. The regions covered in the rheumatic heart disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Cutting-Edge Market Trends Are Expected to Drive the Rheumatic Heart Disease Market’s Growth?

Prominent firms involved in the rheumatic heart disease market are embracing strategic alliances as a means to cultivate innovative methods for treatment and diagnosis. Collaborative ventures in Rheumatic Heart Disease (RHD) management combine skills and resources to promote research and development, enrich therapeutic and diagnostic advancements, broaden market reach, and accelerate commercialisation. For instance, in July 2023, the World Heart Federation (WHF), a non-governmental outfit from Switzerland, and the Philips Foundation, a Dutch nonprofit organisation, joined forces to enhance awareness, medical education, and early detection of Rheumatic Heart Disease (RHD) within the Asia-Pacific (APAC) region. Launched in the Philippines, the project aims at boosting healthcare accessibility for more than half a million vulnerable Filipino children by providing facilities with skilled staff and modern diagnostic instruments. This alliance highlights their shared dedication to fortifying the healthcare systems and guaranteeing timely interventions for RHD patients.

View the full report here:

https://www.thebusinessresearchcompany.com/report/rheumatic-heart-disease-global-market-report

What Are the Key Elements That Define the Rheumatic Heart Disease Market?

Rheumatic heart disease (RHD) is a chronic heart condition caused by permanent damage to the heart valves due to rheumatic fever, an inflammatory disease resulting from untreated or inadequately treated streptococcal throat infections. The immune response triggered by the infection leads to inflammation and scarring of the heart valves, impairing their function and potentially causing heart failure, arrhythmias, or other complications.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=23502

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model